These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 10421323

  • 21. The problems with high dose pancreatic enzyme preparations.
    Taylor CJ.
    Drug Saf; 1994 Aug; 11(2):75-9. PubMed ID: 7946000
    [No Abstract] [Full Text] [Related]

  • 22. Cystic fibrosis colonopathy.
    Lloyd-Still JD, Beno DW, Kimura RM.
    Curr Gastroenterol Rep; 1999 Jun; 1(3):231-7. PubMed ID: 10980955
    [Abstract] [Full Text] [Related]

  • 23. Pancreatic extracts.
    Br Med J; 1970 Apr 18; 2(5702):161-3. PubMed ID: 5440600
    [No Abstract] [Full Text] [Related]

  • 24. Pancreatic extracts.
    Darby CW.
    Br Med J; 1970 May 02; 2(5704):299-300. PubMed ID: 5420197
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Lack of evidence for fibrosing colonopathy by 5-ASA in humans.
    Bakowski MT, Prescott P.
    Dig Dis Sci; 2002 Feb 02; 47(2):469. PubMed ID: 11855570
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparative and experimental pathology of fibrosing colonopathy.
    van Velzen D, Ball LM, Dezfulian AR, Southgate A, Howard CV.
    Postgrad Med J; 1996 Mar 02; 72 Suppl 2():S39-48; discussion S49-51. PubMed ID: 8869182
    [Abstract] [Full Text] [Related]

  • 30. Allergy in cystic fibrosis nurses to pancreatic extract.
    Lipkin GW, Vickers DW.
    Lancet; 1987 Feb 14; 1(8529):392. PubMed ID: 2880202
    [No Abstract] [Full Text] [Related]

  • 31. Tolerability and safety of the long-term administration of pancreatic extracts.
    Gullo L, Pezzilli R, Gaiani S.
    Pancreas; 1997 Mar 14; 14(2):210-2. PubMed ID: 9057197
    [No Abstract] [Full Text] [Related]

  • 32. Fibrosing colonopathy unrelated to pancreatic enzyme supplementation.
    Taylor CJ.
    J Pediatr Gastroenterol Nutr; 2002 Sep 14; 35(3):268-9. PubMed ID: 12352511
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pathogenesis of fibrosing colonopathy: the role of methacrylic acid copolymer.
    Prescott P, Bakowski MT.
    Pharmacoepidemiol Drug Saf; 1999 Oct 14; 8(6):377-84. PubMed ID: 15073899
    [Abstract] [Full Text] [Related]

  • 36. Further comments on fibrosing colonopathy study.
    Dodge JA.
    Lancet; 2001 Nov 03; 358(9292):1546; author reply 1548. PubMed ID: 11705589
    [No Abstract] [Full Text] [Related]

  • 37. Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis.
    Stapleton FB, Kennedy J, Nousia-Arvanitakis S, Linshaw MA.
    N Engl J Med; 1976 Jul 29; 295(5):246-8. PubMed ID: 934188
    [Abstract] [Full Text] [Related]

  • 38. Letter: Pancreatic extract lung sensitivity.
    Feery BJ.
    Med J Aust; 1975 Nov 22; 2(21):809. PubMed ID: 1207574
    [No Abstract] [Full Text] [Related]

  • 39. Fibrosing Colonopathy Presenting in a Patient with Cystinosis.
    Fiore D, Sohini V, Mileti E, Fiore N.
    JPGN Rep; 2023 Aug 22; 4(3):e321. PubMed ID: 37600607
    [Abstract] [Full Text] [Related]

  • 40. Patterns of use of pancreatic enzyme supplements in fibrosing colonopathy: implications for pathogenesis.
    Bakowski MT, Prescott P.
    Pharmacoepidemiol Drug Saf; 1997 Sep 22; 6(5):347-58. PubMed ID: 15073770
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.